Neuroethical issues in cognitive enhancement
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Neuroethics is a developing field, concerned with addressing present and future applied ethical issues brought about directly and indirectly by neuroscience advancements. One domain where neuroscience has begun to have far-reaching ethical implications is in the research and development of pharmaceutical cognitive enhancers. Though such drugs are typically developed to treat cognitive disabilities and improve the quality of life for patients with neuropsychiatric disorders and brain injury, research has found that such drugs can improve performance on cognitive tasks in healthy individuals. In line with such findings is the growing use of these drugs by students and others for cognitive-enhancing purposes. The present paper reviews some of the evidence in both neuropsychiatric and healthy individuals and discusses the implications such research can have for society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Be smart, exercise your heart: Exercise effects on brain and cognition
Hillman, C. H., Erickson, K. I., & Kramer, A. F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2298 · Cited by 3,563
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771 · cited 1×
“Inhibitory motor control has been shown previously to depend, at least in part, on the function of this brain region (Aron et al., 2003).”
BackgroundSelf-citationLong-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis, S. L., Tennstedt, S. L., Marsiske, M., Ball, K., Elias, J., Koepke, K. M., Morris, J. N., Rebok, G. W., Unverzagt, F. W., Stoddard, A. M., et al. (2006) · JAMA · doi:10.1001/jama.296.23.2805 · Cited by 1,496 · cited 2×
“Importantly, there are many others such as education, physical exercise and neurocognitive activation or cognitive training that are commonly being used (Beddington et al., 2008; Hilman et al., 2008; Willis et al., 2006).”
BackgroundModafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713 · cited 3×
“In the case of modafinil (Provigil), despite considerable research its precise mechanism of action is unclear, although it has been found to exhibit a multitude of effects including potentiation of noradrenaline and, to a degree, dopamine neurotransmission (Volkow et al., 2009), elevation of extracellular glutamate, s…”
BackgroundOff-label prescribing among office-based physicians
Radley, D. C., Finkelstein, S. N., & Stafford, R. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.1021 · Cited by 711 · cited 2×
“Off-label prescriptions, or the prescription of a medication for a condition not described in the approved labelling, are very common and legal (Radley et al., 2006), and there is very limited regulation of off-label drugs with prescriptions, relying largely on the physician’s discretion (Hampton,…”
BackgroundAdrenergic pharmacology and cognition: Focus on the prefrontal cortex
Ramos, B. P., & Arnsten, A. F. T. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.006 · Cited by 641
Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-j0004.2000 · Cited by 608 · cited 2×
“In accordance, it is not uncommon for PCEs to improve performance primarily or exclusively in individuals with greater impairment (Mehta et al., 2000).”
BackgroundSelf-citationNeurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573 · cited 2×
“, 2007), but also in healthy adults (Chamberlain et al., 2006).”
BackgroundSelf-citationBeddington, J., Cooper, C. L., Field, J., Goswami, U., Huppert, F. A., Jenkins, R., Jones, H. S., Kirkwood, T. B. L., Sahakian, B. J., & Thomas, S. M. (2008) · Nature · doi:10.1038/4551057a · Cited by 554
Self-citationStahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications
Stahl, S. M. (2021) · doi:10.1017/9781108975292 · Cited by 480
Cited by
Cognitive enhancement by drugs in health and disease
Husain, M., & Mehta, M. A. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.11.002 · Cited by 241
Bari, A., & Aston-Jones, G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.020 · Cited by 85
Lawlor-Savage, L., & Goghari, V. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151817 · Cited by 74
Kim, T. D., Hong, G., Kim, J., & Yoon, S. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.1.1 · Cited by 65
Metadata
- Authors
- Sahakian, B. J., & Morein-Zamir, S.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-03-08
- Volume
- 25
- Issue
- 2
- Pages
- 197-204
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2000407516
- Cited by
- 109
- References
- 17
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroethical issues in cognitive enhancement. https://app.cochat.ai/papers/10.1177/0269881109106926
- The paper
- Sahakian, B. J., & Morein-Zamir, S. (2011). Neuroethical issues in cognitive enhancement. Journal of Psychopharmacology. https://doi.org/10.1177/0269881109106926
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.